These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28789648)

  • 1. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
    Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
    BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
    Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
    PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital burden of pulmonary arterial hypertension in France.
    Bergot E; De Leotoing L; Bendjenana H; Tournier C; Vainchtock A; Nachbaur G; Humbert M
    PLoS One; 2019; 14(9):e0221211. PubMed ID: 31536491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
    Uhart M; Blein C; L'Azou M; Thomas L; Durand L
    Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.
    Kandel M; Allayous C; Dalle S; Mortier L; Dalac S; Dutriaux C; Leccia MT; Guillot B; Saiag P; Lacour JP; Legoupil D; Lesimple T; Aubin F; Beylot-Barry M; Brunet-Possenti F; Arnault JP; Granel-Brocard F; Stoebner PE; Dupuy A; Maubec E; Grob JJ; Dreno B; Rotolo F; Ballon A; Michiels S; Lebbe C; Borget I
    Eur J Cancer; 2018 Dec; 105():33-40. PubMed ID: 30384014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and outcomes in patients with advanced melanoma in France.
    Bedane C; Leccia MT; Sassolas B; Bregman B; Lebbé C;
    Curr Med Res Opin; 2013 Oct; 29(10):1297-305. PubMed ID: 23808961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
    Maravic M; Jouaneton B; Vainchtock A; Tochon V
    Clin Exp Rheumatol; 2012; 30(2):222-7. PubMed ID: 22546070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database.
    Flori YA; le Vaillant M
    Pharmacoeconomics; 2004; 22(16):1061-70. PubMed ID: 15524494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.
    de Zelicourt M; Dardennes R; Verdoux H; Gandhi G; Khoshnood B; Chomette E; Papatheodorou ML; Edgell ET; Even C; Fagnani F
    Pharmacoeconomics; 2003; 21(15):1081-90. PubMed ID: 14596627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient costs of endophthalmitis evaluated for the whole of France.
    Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
    Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
    Weil-Olivier C; Taha MK; Emery C; Bouée S; Beck E; Aris E; Loncle-Provot V; Nachbaur G; Pribil C
    Infect Dis Ther; 2021 Sep; 10(3):1607-1623. PubMed ID: 34170505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
    St Guily JL; Borget I; Vainchtock A; Rémy V; Takizawa C
    Head Neck Oncol; 2010 Sep; 2():22. PubMed ID: 20809978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.
    Colao A; Lucchese M; D'Adamo M; Savastano S; Facchiano E; Veronesi C; Blini V; Degli Esposti L; Sbraccia P
    BMJ Open; 2017 Feb; 7(2):e013899. PubMed ID: 28237961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs associated with hospitalization in HIV-positive patients in France.
    de Léotoing L; Yazdanpanah Y; Finkielsztejn L; Chaize G; Vainchtock A; Nachbaur G; Aubin C; Bonnet F
    AIDS; 2018 Sep; 32(14):2059-2066. PubMed ID: 29894390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
    Allegra C
    Curr Med Res Opin; 2003; 19(8):761-9. PubMed ID: 14687448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.